![Lars Hyveled-Nielsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Hyveled-Nielsen
No más puestos en curso
Historial de carrera de Lars Hyveled-Nielsen
Antiguos cargos conocidos de Lars Hyveled-Nielsen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sanos Bioscience A/S
![]() Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology SANOS Bioscience A/S is a Danish privately owned biotechnology company. Their business is to develop novel treatments for osteoporosis and other skeletal wasting diseases. It was founded in 2003 around patented and proprietary inventions from the Nordic Bioscience Group. This knowledge base includes a profound insight in the biology of skeletal tissue in health, molecular targets, biologicals, and lead compounds. SANOS is focused on the clinical development of SAN-134, an injectable formulation of the intestinal hormone glucagon-like peptide-2, GLP-2 for treatment of diseases with accelerated bone loss, such as osteoporosis. SANOS Bioscience A/S is headquarterd in Copenhagen, Denmark. | Corporate Officer/Principal | - | 01/09/2009 |
Estadísticas
Internacional
Dinamarca | 2 |
Operativa
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Sanos Bioscience A/S
![]() Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology SANOS Bioscience A/S is a Danish privately owned biotechnology company. Their business is to develop novel treatments for osteoporosis and other skeletal wasting diseases. It was founded in 2003 around patented and proprietary inventions from the Nordic Bioscience Group. This knowledge base includes a profound insight in the biology of skeletal tissue in health, molecular targets, biologicals, and lead compounds. SANOS is focused on the clinical development of SAN-134, an injectable formulation of the intestinal hormone glucagon-like peptide-2, GLP-2 for treatment of diseases with accelerated bone loss, such as osteoporosis. SANOS Bioscience A/S is headquarterd in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Lars Hyveled-Nielsen
- Experiencia